Vaxart Inc.
07/28/2026 | Press release | Distributed by Public on 07/28/2026 06:00
Material Event (Form 8-K)
|
Item 8.01
|
Other Events.
|
Reorganization of Committees of the Board of Directors
On July 27, 2026, upon the recommendation of the Nominating and Governance Committee, the Board of Directors of Vaxart, Inc. (the "Board") approved the reorganization of its Nominating and Governance Committee and the Compensation Committee, and the appointments of Kevin P. Finney as chair of the Nominating and Governance Committee and James B. Breitmeyer, M.D., Ph.D. as chair of the Compensation Committee, effective as of August 1, 2026.
Board Committee Appointments
Following this reorganization, the Board appointed its members to serve on the Nominating and Governance Committee and Compensation Committee of the Board as outlined below:
Nominating and Governance Committee
Kevin P. Finney, chair
David Wheadon, M.D.
Compensation Committee
James B. Breitmeyer, M.D., Ph.D., chair
Elaine J. Heron, Ph.D.
W. Mark Watson
Vaxart Inc. published this content on July 28, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on July 28, 2026 at 12:01 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]